Suppr超能文献

非整倍体先于化学致癌作用出现并与之分离。

Aneuploidy precedes and segregates with chemical carcinogenesis.

作者信息

Duesberg P, Li R, Rasnick D, Rausch C, Willer A, Kraemer A, Yerganian G, Hehlmann R

机构信息

Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA.

出版信息

Cancer Genet Cytogenet. 2000 Jun;119(2):83-93. doi: 10.1016/s0165-4608(99)00236-8.

Abstract

A century ago, Boveri proposed that cancer is caused by aneuploidy, an abnormal balance of chromosomes, because aneuploidy correlates with cancer and because experimental aneuploidy generates "pathological" phenotypes. Half a century later, when cancers were found to be nonclonal for aneuploidy, but clonal for somatic gene mutations, this hypothesis was abandoned. As a result, aneuploidy is now generally viewed as a consequence, and mutated genes as a cause of cancer. However, we have recently proposed a two-stage mechanism of carcinogenesis that resolves the discrepancy between clonal mutation and nonclonal karyotypes. The proposal is as follows: in stage 1, a carcinogen "initiates" carcinogenesis by generating a preneoplastic aneuploidy; in stage 2, aneuploidy causes asymmetric mitosis because it biases balance-sensitive spindle and chromosomal proteins and alters centrosomes both numerically and structurally (in proportion to the degree of aneuploidy). Therefore, the karyotype of an initiated cell evolves autocatalytically, generating ever-new chromosome combinations, including neoplastic ones. Accordingly, the heterogeneous karyotypes of "clonal" cancers are an inevitable consequence of the karyotypic instability of aneuploid cells. The notorious long latent periods, of months to decades, from carcinogen to carcinogenesis, would reflect the low probability of evolving by chance karyotypes that compete favorably with normal cells, in principle analagous to natural evolution. Here, we have confirmed experimentally five predictions of the aneuploidy hypothesis: (1) the carcinogens dimethylbenzanthracene and cytosine arabinoside induced aneuploidy in a fraction of treated Chinese hamster embryo cells; (2) aneuploidy preceded malignant transformation; (3) transformation of carcinogen-treated cells occurred only months after carcinogen treatment, i.e., autocatalytically; (4) preneoplastic aneuploidy segregated with malignant transformation in vitro and with 14 of 14 tumors in animals; and (5) karyotypes of tumors were heterogeneous. We conclude that, with the carcinogens studied, aneuploidy precedes cancer and is necessary for carcinogenesis.

摘要

一个世纪前,博韦里提出癌症是由非整倍体引起的,即染色体的异常平衡,因为非整倍体与癌症相关,且实验性非整倍体会产生“病理性”表型。半个世纪后,当发现癌症对于非整倍体而言是非克隆性的,但对于体细胞基因突变却是克隆性的时,这一假说被摒弃。结果,现在非整倍体通常被视为癌症的一个后果,而突变基因则被看作是癌症的起因。然而,我们最近提出了一种致癌的两阶段机制,该机制解决了克隆性突变与非克隆性核型之间的差异。提议如下:在第一阶段,致癌物通过产生肿瘤前非整倍体“启动”致癌过程;在第二阶段,非整倍体导致不对称有丝分裂,因为它使对平衡敏感的纺锤体和染色体蛋白产生偏差,并在数量和结构上改变中心体(与非整倍体程度成比例)。因此,起始细胞的核型会自动催化进化,产生不断更新的染色体组合,包括肿瘤性的组合。相应地,“克隆性”癌症的异质核型是非整倍体细胞核型不稳定的必然结果。从致癌物接触到致癌过程长达数月至数十年的臭名昭著的长潜伏期,将反映出偶然进化出与正常细胞竞争有利的核型的低概率,原则上类似于自然进化。在此,我们通过实验证实了非整倍体假说的五个预测:(1)致癌物二甲基苯并蒽和阿糖胞苷在一部分经处理的中国仓鼠胚胎细胞中诱导了非整倍体;(2)非整倍体先于恶性转化;(3)致癌物处理后的细胞转化仅在致癌物处理数月后发生,即自动催化发生;(4)肿瘤前非整倍体在体外与恶性转化以及在动物的14个肿瘤中的14个中与肿瘤分离;(5)肿瘤的核型是异质的。我们得出结论,对于所研究的致癌物,非整倍体先于癌症出现,并且是致癌过程所必需的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验